Sign in
Explore the registryTrack Belantamab mafodotin's trials

DREAMM 8

All Japanese Population: Belantamab Mafodotin Plus Pomalidomide and Dexamethasone (Pd) Versus Bortezomib Plus Pd in Relapsed/Refractory Multiple Myeloma

Belantamab mafodotinOngoingActive not recruitingPhase 3Open NCT06956170 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…